Latest News and Press Releases
Want to stay updated on the latest news?
-
YOQNEAM, Israel, July 31, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd. (Nasdaq:GIVN) today announced the results of its annual shareholders' meeting which was held today in Yoqneam, Israel. A total of...
-
YOQNEAM, Israel, July 23, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN) today announced that the company will host a conference call on Wednesday, August 7, 2013 at 9:00am ET, 4:00pm Israel...
-
Broad Indication Could Benefit Over One Million Patients Per Year in Japan Significantly Broadens Given Imaging's Potential Capsule Endoscopy System Customer Base YOQNEAM, Israel, July 15, 2013...
-
ORLANDO, Fla., May 21, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced that numerous studies presented...
-
- Secondary Analysis by Dr. Rex of sub-set of PillCam COLON trial data shows sensitivity for detecting adenomas that are at least 6 mm and 10 mm to be 88% and 92% respectively and specificity to be...
-
-- Additional Study Highlights Improved Diagnostic Yield for New 12-Hour PillCam SB -- -- Celebrates Two Millionth PillCam Milestone -- ORLANDO, Fla., May 21, 2013 (GLOBE NEWSWIRE) -- Given...
-
Other studies confirm PillCam COLON useful in detecting flat lesions and evaluating pediatric ulcerative colitis Additional comparative trial finds capsule endoscopy superior to Magnetic...
-
ORLANDO, Fla., May 20, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced several studies confirming an...
-
YOQNEAM, Israel, May 13, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced that numerous studies...
-
– First Quarter 2013 Revenues of $40.6 million – – First Quarter 2013 GAAP and Non-GAAP EPS ($0.01) and $0.05, Respectively – – First Quarter 2013 GAAP and Non-GAAP...